Clinical application of ghrelin in the field of surgery

Shuji Takiguchi, Kohei Murakami, Yoshitomo Yanagimoto, Akihiro Takata, Yasuhiro Miyazaki, Masaki Mori, Yuichiro Doki

Research output: Contribution to journalReview article

19 Citations (Scopus)

Abstract

Ghrelin was discovered as an intrinsic ligand for the growth hormone (GH)-secretagogue receptor (GHS-R) in 1999. The endogenous production of ghrelin occurs mainly in the stomach. Ghrelin has multiple functions; it has orexigenic action, stimulates GH secretion, has anti-inflammatory activities, stimulates gastrointestinal activity, stabilizes heart function and has other metabolic roles. Moreover, ghrelin is the only gastrointestinal hormone known to stimulate appetite. In the past decade, clinical applications of ghrelin have been attempted for various pathologies, based on its anabolic function, including applications for patients with anorexia nervosa and cachexia due to chronic heart, renal or pulmonary diseases. In the field of surgery, we have conducted several clinical trials using exogenous ghrelin in patients undergoing total gastrectomy, esophagectomy and neoadjuvant chemotherapy, including cisplatin treatment, and consistently obtained unique and striking benefits in these patients. Ghrelin comprehensively improves the patients’ general conditions and quality of life via its pleiotropic physiological functions. This characteristic is unique and different from the existing drugs; therefore, ghrelin may be an indispensable supplement to prevent surgical stress and postoperative sequelae. This review summarizes the recent advances toward the clinical application of ghrelin.

Original languageEnglish
Pages (from-to)801-807
Number of pages7
JournalSurgery today
Volume45
Issue number7
DOIs
Publication statusPublished - Nov 1 2015
Externally publishedYes

Fingerprint

Ghrelin
Ghrelin Receptor
Gastrointestinal Hormones
Cachexia
Esophagectomy
Anorexia Nervosa
Appetite
Gastrectomy
Chronic Renal Insufficiency
Cisplatin
Lung Diseases
Growth Hormone
Heart Diseases
Stomach
Anti-Inflammatory Agents
Quality of Life
Clinical Trials
Pathology
Ligands
Drug Therapy

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Takiguchi, S., Murakami, K., Yanagimoto, Y., Takata, A., Miyazaki, Y., Mori, M., & Doki, Y. (2015). Clinical application of ghrelin in the field of surgery. Surgery today, 45(7), 801-807. https://doi.org/10.1007/s00595-014-1040-z

Clinical application of ghrelin in the field of surgery. / Takiguchi, Shuji; Murakami, Kohei; Yanagimoto, Yoshitomo; Takata, Akihiro; Miyazaki, Yasuhiro; Mori, Masaki; Doki, Yuichiro.

In: Surgery today, Vol. 45, No. 7, 01.11.2015, p. 801-807.

Research output: Contribution to journalReview article

Takiguchi, S, Murakami, K, Yanagimoto, Y, Takata, A, Miyazaki, Y, Mori, M & Doki, Y 2015, 'Clinical application of ghrelin in the field of surgery', Surgery today, vol. 45, no. 7, pp. 801-807. https://doi.org/10.1007/s00595-014-1040-z
Takiguchi S, Murakami K, Yanagimoto Y, Takata A, Miyazaki Y, Mori M et al. Clinical application of ghrelin in the field of surgery. Surgery today. 2015 Nov 1;45(7):801-807. https://doi.org/10.1007/s00595-014-1040-z
Takiguchi, Shuji ; Murakami, Kohei ; Yanagimoto, Yoshitomo ; Takata, Akihiro ; Miyazaki, Yasuhiro ; Mori, Masaki ; Doki, Yuichiro. / Clinical application of ghrelin in the field of surgery. In: Surgery today. 2015 ; Vol. 45, No. 7. pp. 801-807.
@article{b1477371128e4b3e871844c6b3cff892,
title = "Clinical application of ghrelin in the field of surgery",
abstract = "Ghrelin was discovered as an intrinsic ligand for the growth hormone (GH)-secretagogue receptor (GHS-R) in 1999. The endogenous production of ghrelin occurs mainly in the stomach. Ghrelin has multiple functions; it has orexigenic action, stimulates GH secretion, has anti-inflammatory activities, stimulates gastrointestinal activity, stabilizes heart function and has other metabolic roles. Moreover, ghrelin is the only gastrointestinal hormone known to stimulate appetite. In the past decade, clinical applications of ghrelin have been attempted for various pathologies, based on its anabolic function, including applications for patients with anorexia nervosa and cachexia due to chronic heart, renal or pulmonary diseases. In the field of surgery, we have conducted several clinical trials using exogenous ghrelin in patients undergoing total gastrectomy, esophagectomy and neoadjuvant chemotherapy, including cisplatin treatment, and consistently obtained unique and striking benefits in these patients. Ghrelin comprehensively improves the patients’ general conditions and quality of life via its pleiotropic physiological functions. This characteristic is unique and different from the existing drugs; therefore, ghrelin may be an indispensable supplement to prevent surgical stress and postoperative sequelae. This review summarizes the recent advances toward the clinical application of ghrelin.",
author = "Shuji Takiguchi and Kohei Murakami and Yoshitomo Yanagimoto and Akihiro Takata and Yasuhiro Miyazaki and Masaki Mori and Yuichiro Doki",
year = "2015",
month = "11",
day = "1",
doi = "10.1007/s00595-014-1040-z",
language = "English",
volume = "45",
pages = "801--807",
journal = "Surgery Today",
issn = "0941-1291",
publisher = "Springer Japan",
number = "7",

}

TY - JOUR

T1 - Clinical application of ghrelin in the field of surgery

AU - Takiguchi, Shuji

AU - Murakami, Kohei

AU - Yanagimoto, Yoshitomo

AU - Takata, Akihiro

AU - Miyazaki, Yasuhiro

AU - Mori, Masaki

AU - Doki, Yuichiro

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Ghrelin was discovered as an intrinsic ligand for the growth hormone (GH)-secretagogue receptor (GHS-R) in 1999. The endogenous production of ghrelin occurs mainly in the stomach. Ghrelin has multiple functions; it has orexigenic action, stimulates GH secretion, has anti-inflammatory activities, stimulates gastrointestinal activity, stabilizes heart function and has other metabolic roles. Moreover, ghrelin is the only gastrointestinal hormone known to stimulate appetite. In the past decade, clinical applications of ghrelin have been attempted for various pathologies, based on its anabolic function, including applications for patients with anorexia nervosa and cachexia due to chronic heart, renal or pulmonary diseases. In the field of surgery, we have conducted several clinical trials using exogenous ghrelin in patients undergoing total gastrectomy, esophagectomy and neoadjuvant chemotherapy, including cisplatin treatment, and consistently obtained unique and striking benefits in these patients. Ghrelin comprehensively improves the patients’ general conditions and quality of life via its pleiotropic physiological functions. This characteristic is unique and different from the existing drugs; therefore, ghrelin may be an indispensable supplement to prevent surgical stress and postoperative sequelae. This review summarizes the recent advances toward the clinical application of ghrelin.

AB - Ghrelin was discovered as an intrinsic ligand for the growth hormone (GH)-secretagogue receptor (GHS-R) in 1999. The endogenous production of ghrelin occurs mainly in the stomach. Ghrelin has multiple functions; it has orexigenic action, stimulates GH secretion, has anti-inflammatory activities, stimulates gastrointestinal activity, stabilizes heart function and has other metabolic roles. Moreover, ghrelin is the only gastrointestinal hormone known to stimulate appetite. In the past decade, clinical applications of ghrelin have been attempted for various pathologies, based on its anabolic function, including applications for patients with anorexia nervosa and cachexia due to chronic heart, renal or pulmonary diseases. In the field of surgery, we have conducted several clinical trials using exogenous ghrelin in patients undergoing total gastrectomy, esophagectomy and neoadjuvant chemotherapy, including cisplatin treatment, and consistently obtained unique and striking benefits in these patients. Ghrelin comprehensively improves the patients’ general conditions and quality of life via its pleiotropic physiological functions. This characteristic is unique and different from the existing drugs; therefore, ghrelin may be an indispensable supplement to prevent surgical stress and postoperative sequelae. This review summarizes the recent advances toward the clinical application of ghrelin.

UR - http://www.scopus.com/inward/record.url?scp=84930868080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930868080&partnerID=8YFLogxK

U2 - 10.1007/s00595-014-1040-z

DO - 10.1007/s00595-014-1040-z

M3 - Review article

VL - 45

SP - 801

EP - 807

JO - Surgery Today

JF - Surgery Today

SN - 0941-1291

IS - 7

ER -